FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Clindamycin Injection
Status: Discontinuation
»Therapeutic Categories: Anti-Infective

Expand all

Mylan Institutional, a Viatris company (New 06/01/2021)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
6 mL/vial (NDC 67457-816-06) 10/23/2020 Discontinuation of the manufacture of the drug.
150 mg/1 mL; 4 mL in 1 vial, Single dose; 25 vial/carton (NDC 67457-815-04) 01/08/2021 Discontinuation of the manufacture of the drug.
300 mg/ 2 mL; Solution in Single Dose Vials (containing preservatives) (NDC 67457-814-02) 06/01/2021 Discontinuation of the manufacture of the drug.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English